17 unknown. 17 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 17 | Unknown 17 |
Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease Saffron, Placebo - Ulcerative Colitis | Phase 4 | Unknown | Minia University | 90 | 2023-03-30 | 2023-03-17 |
| Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease Intravenous iron, Ferric maltol, Ferrous fumarate - Inflammatory Bowel Diseases, Iron-deficiency | Phase 4 | Unknown | Leiden University Medical Center | 90 | 2022-08-19 | 2023-03-31 |
| Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis Mesalazine - Ulcerative Colitis | Phase 4 | Unknown | Flemming Bendtsen | 200 | 2019-11-28 | 2023-09-26 |
| Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis Vedolizumab - Ulcerative Colitis | Phase 4 | Unknown | Guy's and St Thomas' NHS Foundation Trust | 30 | 2019-07-01 | 2019-07-08 |
| Optimization of Golimumab Treatment in Ulcerative Colitis Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg, Golimumab treatment optimization. - Colitis, Ulcerative | Phase 4 | Unknown | Hospital de Manises | 50 | 2018-10-01 | 2018-09-13 |
| Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients Sodium Picosulfate/Magnesium Citrate Laxative, 2L polyethylene glycol/ascorbic acid - Ulcerative Colitis | Phase 4 | Unknown | American University of Beirut Medical Center | 68 | 2018-03-26 | 2019-09-19 |
| Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis Azathioprine, Infliximab - Colitis, Ulcerative | Phase 4 | Unknown | Istituto Clinico Humanitas | 100 | 2017-05-08 | 2017-05-12 |
| Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis Mesalazine, hydrocortisone sodium succinate, Mesalazine with hydrocortisone sodium succinate - Ulcerative Colitis, Unspecified | Phase 4 | Unknown | Xijing Hospital of Digestive Diseases | 528 | 2017-05-01 | 2017-04-12 |
| Golimumab Dried Blood Spot Analysis Cohort A, Cohort B - Ulcerative Colitis | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 10 | 2016-12-01 | 2017-10-27 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing fecal microbiota transplantation, Saline - Ulcerative Colitis | Phase 4 | Unknown | The Second Hospital of Nanjing Medical University | 188 | 2016-12-01 | 2016-12-20 |
| Anemia in Inflammatory Bowel Disease oral liposomal iron - Anemia, Bowel Diseases, Inflammatory | Phase 4 | Unknown | Federal University of Juiz de Fora | 200 | 2016-08-01 | 2016-08-09 |
| Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis Golimumab (GLM) - Colitis | Phase 4 | Unknown | University College Dublin | 136 | 2016-06-01 | 2018-07-19 |
| "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Infliximab-Biosimilar, Infliximab-Innovator - Colitis, Ulcerative, Crohn's Disease | Phase 4 | Unknown | Onze Lieve Vrouwe Gasthuis | 300 | 2015-08-01 | 2015-05-22 |
| Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Golimumab - Colitis, Ulcerative | Phase 4 | Unknown | Istituto Clinico Humanitas | 100 | 2015-03-01 | 2015-04-08 |
| Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Golimumab - Ulcerative Colitis | Phase 4 | Unknown | Kliniken im Naturpark Altmuehltal | 50 | 2014-06-01 | 2014-07-10 |
| The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation probiotics, placebo - Crohn's Disease, Ulcerative Colitis | Phase 4 | Unknown | The Baruch Padeh Medical Center, Poriya | 100 | 2012-12-01 | 2011-08-11 |
| Role of Healthy Bacteria in Ulcerative Colitis Control, Probiotic - Ulcerative Colitis | Phase 4 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 100 | 2011-03-01 | 2011-11-24 |
Colitis, Ulcerative (16) · Crohn Disease (4) · Inflammatory Bowel Diseases (4) · Anemia (1) · Anemia, Iron-Deficiency (1) · Iron Deficiencies (1)
Colonic Diseases (17) · Digestive System Diseases (17) · Gastroenteritis (17) · Gastrointestinal Diseases (17) · Intestinal Diseases (17) · Inflammatory Bowel Diseases (12) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Anemia (1) · Anemia, Hypochromic (1) · Iron Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
golimumab (4) · Mesalamine (2) · Probiotics (2) · Ascorbic Acid (1) · Azathioprine (1) · Fecal Microbiota Transplantation (1) · Hydrocortisone (1) · Infliximab (1) · MoviPrep (1) · Polyethylene Glycols (1) · Sodium Chloride (1) · ferric maltol (1) · ferric pyrophosphate (1) · ferrous fumarate (1) · picosulfate sodium (1)
Istituto Clinico Humanitas (2) · American University of Beirut Medical Center (1) · Federal University of Juiz de Fora (1) · Flemming Bendtsen (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Hospital de Manises (1) · Kliniken im Naturpark Altmuehltal (1) · Leiden University Medical Center (1) · Minia University (1) · Onze Lieve Vrouwe Gasthuis (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · The Baruch Padeh Medical Center, Poriya (1) · The Second Hospital of Nanjing Medical University (1) · Universitaire Ziekenhuizen KU Leuven (1) · University College Dublin (1)
China (2) · Italy (2) · Belgium (1) · Denmark (1) · Egypt (1) · Germany (1) · India (1) · Ireland (1) · Lebanon (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Bikash Medhi, MD (1) · Carla VA Antunes, MSc. MD (1) · Flemming Bendtsen, MDSci (1) · Glen Doherty (1) · Marc Ferrante, MD PhD (1) · Matthias G Breidert, MD (1) · Silvio Danese, MD, PhD (1)
PMID 24572205, PMID 25168749, PMID 25705682, PMID 25836986, PMID 25857665, PMID 26363929, PMID 26765407, PMID 30564993, PMID 38296290, PMID 40013523, PMID 40955556, PMID 42261111
2018 (1)